Skip to content
OpenCapital
Get started

USANA Health Sciences USNA Greater China — Net Sales

Other geography segments

Americas and Europe
$80.87M+6.2%
Southeast Asia Pacific
$30.66M-14.2%
North Asia
$15.35M-18.9%

Similar metrics at other companies

Viatris logo
VTRSGreater China — Net Sales
$680.1M+22.4%
Apple logo
AAPLGreater China — Net Sales
$20.5B+28.1%
Tapestry, Inc. logo
TPRGreater China — Net Sales
$432.2M+55.0%
NovoCure logo
NVCRGreater China — Net revenues
$4.8M+3.9%
Imax logo
IMAXGreater China — Revenue
$20.57M-48.7%
DCH
DCHChina — Net Sales
$60.68M-26.2%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0×0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's greater china — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's greater china — net sales?
USANA Health Sciences (USNA) reported greater china — net sales of $123.33M in Q1 2026.
How has USANA Health Sciences's greater china — net sales changed year-over-year?
USANA Health Sciences's greater china — net sales increased by 3.9% year-over-year, from $118.75M to $123.33M.
What is the long-term trend for USANA Health Sciences's greater china — net sales?
Over 4 years (2021 to 2025), USANA Health Sciences's greater china — net sales has grown at a -6.8% compound annual growth rate (CAGR), from $563.47M to $424.54M.
What does greater china — net sales mean?
This metric represents the total revenue generated from the sale of nutritional and personal-care products within the Greater China geographic region. It serves as a key indicator of market penetration, consumer demand, and the effectiveness of the direct selling model in this specific territory. Monitoring this figure helps investors assess the company's regional growth trajectory and its ability to navigate local market dynamics.